Beijing Leadman Biochemistry Co Ltd Financial Flexibility Index
Beijing Leadman Biochemistry Co Ltd financial flexibility index. Beijing Leadman Biochemistry Co Ltd (300289) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of CN¥13.28 Million (operating CF CN¥11.89 Million minus capex CN¥1.40 Million) represents 0% of total liabilities (CN¥96.51 Million). See Beijing Leadman Biochemistry Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Beijing Leadman Biochemistry Co Ltd (2008–2025)
Financial flexibility index of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Beijing Leadman Biochemistry Co Ltd across 18 annual periods. Check Beijing Leadman Biochemistry Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Beijing Leadman Biochemistry Co Ltd Financial Flexibility Index by Year (2008–2025)
Beijing Leadman Biochemistry Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Beijing Leadman Biochemistry Co Ltd. For the full cash flow conversion analysis, see Beijing Leadman Biochemistry Co Ltd (300289) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥46.75 Million | CN¥29.16 Million | CN¥105.46 Million | ▼ -49.8% |
| 2024 | 0.88x | CN¥91.63 Million | CN¥62.41 Million | CN¥103.84 Million | ▼ -22.9% |
| 2023 | 1.14x | CN¥153.11 Million | CN¥134.42 Million | CN¥133.77 Million | ▲ +67.5% |
| 2022 | 0.68x | CN¥148.05 Million | CN¥108.93 Million | CN¥216.67 Million | ▲ +54.7% |
| 2021 | 0.44x | CN¥163.56 Million | CN¥119.06 Million | CN¥370.30 Million | ▼ -32.7% |
| 2020 | 0.66x | CN¥163.95 Million | CN¥135.56 Million | CN¥249.92 Million | ▲ +14.8% |
| 2019 | 0.57x | CN¥150.93 Million | CN¥124.65 Million | CN¥264.18 Million | ▲ +78.7% |
| 2018 | 0.32x | CN¥93.26 Million | CN¥81.02 Million | CN¥291.80 Million | ▼ -20.3% |
| 2017 | 0.40x | CN¥131.87 Million | CN¥120.97 Million | CN¥328.73 Million | ▲ +24.5% |
| 2016 | 0.32x | CN¥105.09 Million | CN¥81.78 Million | CN¥326.13 Million | ▼ -36.6% |
| 2015 | 0.51x | CN¥202.54 Million | CN¥177.82 Million | CN¥398.76 Million | ▲ +4364.0% |
| 2014 | 0.01x | CN¥5.96 Million | CN¥-13.21 Million | CN¥523.48 Million | ▼ -98.2% |
| 2013 | 0.62x | CN¥243.79 Million | CN¥90.45 Million | CN¥392.86 Million | ▼ -23.6% |
| 2012 | 0.81x | CN¥300.02 Million | CN¥57.86 Million | CN¥369.17 Million | ▼ -17.6% |
| 2011 | 0.99x | CN¥142.84 Million | CN¥29.34 Million | CN¥144.89 Million | ▲ +6.0% |
| 2010 | 0.93x | CN¥92.09 Million | CN¥53.46 Million | CN¥98.99 Million | ▼ -4.3% |
| 2009 | 0.97x | CN¥46.33 Million | CN¥31.26 Million | CN¥47.68 Million | ▲ +4.0% |
| 2008 | 0.93x | CN¥28.02 Million | CN¥21.98 Million | CN¥30.01 Million | — |